The Cardiac Ablation Market: Projected Growth to $8.6 Billion by 2033 The cardiac ablation market is set to grow significantly, reaching $8.6 billion globally by 2033, fueled by advancements and increasing demand.

The Cardiac Ablation Market: Projected Growth to $8.6 Billion by 2033 #None #Medical_Devices #electrophysiology #cardiac_ablation

Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference Field Medical Inc. is set to unveil its groundbreaking cardiac ablation platform at the 44th J.P. Morgan Annual Healthcare Conference.

Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference #USA #San_Francisco #Field_Medical #FieldForce #cardiac_ablation

Medtronic Reports Robust Second Quarter Results, Efforts Accelerate for Growth Medtronic has delivered impressive financial results for Q2 FY26, showcasing strong growth across multiple sectors, particularly in cardiac care and diabetes management.

Medtronic Reports Robust Second Quarter Results, Efforts Accelerate for Growth #Ireland #Medtronic #Galway #cardiac_ablation #Hugo_Robotic

Field Medical Secures $35 Million Series B Funding to Revolutionize Cardiac Care with Advanced Ablation Technology Field Medical, a pioneering company in cardiac ablation technology, recently closed a $35 million Series B round to enhance its innovative FieldForce™ system aimed at treating ventricular tachycardia.

Field Medical Secures $35 Million Series B Funding to Revolutionize Cardiac Care with Advanced Ablation Technology #USA #Cardiff-by-the-Sea #Field_Medical #FieldForce #cardiac_ablation

Field Medical Secures $35 Million to Propel Innovative Cardiac Ablation Technology Forward Field Medical has successfully closed a $35 million Series B financing round aimed at advancing the development of its FieldForce™ Pulsed Field Ablation platform to treat complex cardiac conditions.

Field Medical Secures $35 Million to Propel Innovative Cardiac Ablation Technology Forward #USA #Cardiff-by-the-Sea #Field_Medical #FieldForce #cardiac_ablation

Field Medical Secures $40 Million to Transform Cardiac Ablation Technology for Ventricular Tachycardia Field Medical Inc. has raised $40 million in Series A funding to enhance its pulsed field ablation technology for ventricular tachycardia and atrial fibrillation, driving innovation in cardiac care.

Field Medical Secures $40 Million to Transform Cardiac Ablation Technology for Ventricular Tachycardia #USA #Ventricular_Tachycardia #Cardiff-by-the-Sea #Field_Medical #cardiac_ablation

Field Medical Secures $40 Million Series A Financing to Transform Cardiac Ablation Technology Field Medical Inc. has successfully closed a $40 million Series A financing round to advance its innovative cardiac pulsed field ablation technology targeting ventricular tachycardia.

Field Medical Secures $40 Million Series A Financing to Transform Cardiac Ablation Technology #United_States #Ventricular_Tachycardia #Cardiff-by-the-Sea #Field_Medical #cardiac_ablation